Digital tool to help with allergy shot adherence
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a digital tool designed to help patients stick to their allergy immunotherapy schedule. If you have allergic rhinitis (with or without asthma) and are starting a new single-allergy treatment, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are starting a new allergy immunotherapy (allergy shots or drops) for the first time in at least 3 years.
- You must have only one allergy product prescribed (not multiple).
- Your treatment is given under the tongue or as a shot (not by other methods).
- You have allergic rhinitis (hay fever) with or without asthma (not asthma alone).
- You can provide a photo of your medication when you begin the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital platform to help manage allergic rhinitis (nasal allergies) and sinusitis. It's for adults whose symptoms are not well controlled despite treatment.
This trial tests if an app can predict and warn you about allergic rhinitis caused by pollen. You'll use the MASK-air app daily to track your symptoms.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This study uses a nasal allergen “provocation” test to help decide how to start and monitor allergy immunotherapy (allergy shots or drops). It may help doctors better track whether the treatment is working for people with allergic rhinitis.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.